ArticleNPJ digital medicine2025
GLANCE: continuous global-local exchange with consensus fusion for robust nodule segmentation.
Article in NPJ digital medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Accurate segmentation and detection of pulmonary nodules from computed tomography (CT) scans are critical for early lung cancer diagnosis but are hindered by the high diversity of nodule characteristics and the limitations of existing deep learning models. Conventional convolutional neural networks struggle with long-range context, while Transformers can neglect fine local details. We present GLANCE (Continuous Global-Local Exchange with Consensus Fusion), a novel dual-stream architecture designed to overcome these limitations. GLANCE features two parallel, co-evolving branches: a global context transformer to model long-range dependencies and a multi-receptive grouped atrous mixer to capture fine-grained local details. The core innovation is the cross-scale consensus fusion mechanism, which continuously integrates these complementary feature streams at every hierarchical scale, preventing representational clashes and promoting synergistic learning. A dual-head pyramid refinement decoder leverages these fused features to perform simultaneous nodule segmentation and center heatmap detection. Validated on four public benchmarks (LIDC-IDRI, LNDb, LUNA16, and Tianchi), GLANCE establishes a new state-of-the-art in both segmentation and detection. An extensive ablation study confirms that each architectural component, particularly the continuous fusion strategy, is critical to its superior performance.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.